EZH2 and cancer: Our MTT assays over a 4-day time course showed that individual knockdown of H1.2 and EZH2 in MCF7, LD611 and LNCaP cancer cells gradually decreased cell proliferation rates (Fig. 4H,I, Fig. S3F,G).